secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aravive, Inc. (—)
CIK:        0001513818
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001437749-23-026308
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aravive fails to meet three Nasdaq listing standards; cure period to March 13, 2024
--------------------------------------------------------------------------------

- MVLS below $50M for 30 consecutive business days (Aug 3-Sep 14, 2023); 180-day cure ends March 13, 2024.
- MVPHS below $15M over same period; compliance requires closing at $15M+ for 10 consecutive days.
- Minimum bid price below $1.00 for 30 consecutive days; same cure period applies.
- If not cured by March 13, 2024, Nasdaq may delist; company can appeal or apply to transfer to Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513818/000143774923026308/0001437749-23-026308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513818/000143774923026308/arav20230918_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-026308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer